Throne is scaling discreet diagnostics.
What’s happening: The company raised a $10M Series A to expand use cases for its AI-powered toilet-affixed sensor beyond gut health.
Smooth move. Debuting in March, Throne’s device uses computer vision to decode bowel movements for consistency, hydration, and urinary patterns — delivering clinical gut health signals to its app.
Expanding guidance with a conversational AI coach, co-founder & CEO Scott Hickle indicated new funding will advance its next-gen device, which aims to flag early signs of colon cancer.
Second seating. From probiotic-obsessed and fibermaxxing consumers to the ~40% of the world with a GI disorder, gut health will soon become a $105B market.
Navigating stigma and privacy concerns, bathroom companions from Withings and Kohler are aiming to make once subjective observation the new clinical signal, while Casana changes detection points. As colorectal cancer surges in younger, tech-savvy users, Throne wants to make screening a daily business.
Punchline: Like wrist wearables, toilet tech is stopping just short of diagnosis — while revealing the clinical potential of unobtrusive, always-on monitoring.
